Difference between revisions of "Duvelisib (Copiktra)"

Revision as of 03:28, 6 January 2015

PI3K-δ,γ inhibitor

Abstract: Manish Patel, Brad S. Kahl, Steven M. Horwitz, Francine M. Foss, Yasuhiro Oki, Pierluigi Porcu, Jennifer Sweeney, Kerstin Allen, Kerrie Faia, Patricia Harris, Joi Dunbar, Howard M. Stern, Patrick Kelly, Susan O'Brien. Preliminary Safety and Efficacy Of IPI-145, a Potent Inhibitor Of Phosphoinositide-3-Kinase-δ,γ, In Patients With Chronic Lymphocytic Leukemia. Blood Nov 2013,122(21)677 link to original abstract

Revision as of 03:31, 26 November 2014 (view source) Jwarner (talk \| contribs) m ← Older edit	Revision as of 03:28, 6 January 2015 (view source) Jwarner (talk \| contribs) m (Jwarner moved page IPI-145 to Duvelisib (IPI-145)) Newer edit →
(No difference)